WHO clinical stage at start of antiretroviral treatment at Arba Minch Hospital, 2010.
收藏数据链接：
官方服务：
资源简介：
Chi–square for trend (X2 = 83.3; df = 1; P
应用场景：
创建时间：
2015-12-02
相关数据集
ATN015 HIV Related Diagnosis Form [CRF 2A] Dataset in Short-Cycle Therapy in Adolescents Following Continuous Therapy with Established Viral Suppression: The Impact on Viral Load Suppression
Data from HIV Related Diagnosis Form [CRF 2A] Study Description A prospective proof of concept study of subjects who had successfully suppressed their HIV-1 RNA levels for a minimum of 6 months prior
NIAID Data Ecosystem80
Characteristics of patients meeting criteria for treatment initiation during follow-up in chronic infection, according to whether treatment was initiated, or not, during the 6 following months; the ANRS PRIMO and COPANA cohorts.
*Odds Ratio for not initiating ART, adjusted for viral load, gender, country of birth, living conditions, educational level, clinic center size and calendar period. The % (n) are based on the number o
NIAID Data Ecosystem70
ATN 061 Chemistry Results Primary Dataset in Preservation and Expansion of T-cell Subsets Following HAART De-intensification to Atazanavir/ritonavir (ATV/r) in Adolescents and Young Adults with CD4 + T Cells > 350 cells/mm3 Initiating HAART
Data from Chemistry Results Form [CRF 11, questions 1-2, 3-4, 5, and 6 and 6a for version 1] Study Description A randomized, proof-of-concept study of adolescents and young adults aged 18-24 years wit
NIAID Data Ecosystem40
ATN 024 Antiretroviral Medications: Other Antiretroviral Medication Listing [CRF 4] Dataset in A Randomized, Open-Label Trial of Three Hepatitis B Vaccination Schemas in HIV-Positive Youth
Data from Antiretroviral Medications Form: Other Antiretroviral Medication Listing [CRF 4] Study Description Suboptimal response to hepatitis B vaccination in HIV-positive adults and children has been
NIAID Data Ecosystem70
ATN 061 CDC Classification Dataset in Preservation and Expansion of T-cell Subsets Following HAART De-intensification to Atazanavir/ritonavir (ATV/r) in Adolescents and Young Adults with CD4 + T Cells > 350 cells/mm3 Initiating HAART
Data from HIV and Non-HIV Diagnoses Form [CRF 5, questions 2-3] Study Description A randomized, proof-of-concept study of adolescents and young adults aged 18-24 years with confirmed HIV acquired afte
NIAID Data Ecosystem60
